Metabolic Flexibility to Predict Lifestyle Interventions Outcomes
Recruiting now · Not applicable
Conditions studied: Obesity
In brief
Weight loss is a cornerstone of diabetes (T2D) management, yet in clinical practice, its delivery is limited by its perceived burdensome nature and variability in response. Personalization of the interventions to increase their success rate is an unmet clinical need. The proposed project MEPHISTO (Whole body and gut microbiome metabolic flexibility to predict lifestyle intervention outcomes) would aim to identify predictive features related to successful weight loss upon sequential exercise and diet intervention in people living with obesity. To this end, the study aims to conduct a clinical trial where the investigators would implement state-of-the-art physiological phenotyping of metabolic flexibility at the whole-body level and at the level of the gut in persons with obesity before and after exercise and diet + exercise intervention to identify predictive signatures of successful weight loss
Key facts
- Study ID
- NCT06329349
- Run by
- Charles University, Czech Republic
- People needed
- 30
- Starts
- 2024-01-02
- Expected to finish
- 2026-04-01
- Last updated by the study team
- 2024-08-28
Who can join
Age: 25 and older, up to 45. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- BMI>30
- age 25-45 years
You may not qualify if…
- active cancer
- diabetes (medical history, fasting glycemia >7.6 and/or 2hOGTT glycemia >11.1)
- uncontrolled endocrine diseases
- corticosteroid therapy
- immune-suppressive therapy
- pregnancy
- breastfeeding
Where it is running
- University Hospital Kralovske Vinohrady — Prague, Czechia (enrolling)
- Third Medical Faculty,Charles University — Prague, Czechia (enrolling)
- Faculty of Sports Science — Prague, Czechia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.